Emerging modalities are driving the future of the biopharma industry, and pharmaceutical companies are increasingly turning to external sources for these innovations. This panel brings together speakers from top tier pharmaceutical companies to discuss trends in sourcing innovation, the evaluation and diligence process, current areas of focus, and considerations on timing of a partnership. Panelists will share evaluation criteria and strategic priorities that drive their partnership decisions. Additionally, the discussion will cover when to engage and how to assess upcoming value inflection points to maximize value. Attendees will gain insights on current trends, sought-after assets, and anticipated future developments in the therapeutics market.